Literature DB >> 23332588

Atrial fibrillation and risk of stroke in dialysis patients.

James B Wetmore1, Edward F Ellerbeck, Jonathan D Mahnken, Milind Phadnis, Sally K Rigler, Purna Mukhopadhyay, John A Spertus, Xinhua Zhou, Qingjiang Hou, Theresa I Shireman.   

Abstract

PURPOSE: Both stroke and chronic atrial fibrillation (AF) are common in dialysis patients, but uncertainty exists in the incidence of new strokes and the risk conferred by chronic AF.
METHODS: A cohort of dually eligible (Medicare and Medicaid) incident dialysis patients was constructed. Medicare claims were used to determine the onset of chronic AF, which was specifically treated as a time-dependent covariate. Cox proportional hazards models were used to model time to stroke.
RESULTS: Of 56,734 patients studied, 5629 (9.9%) developed chronic AF. There were 22.8 ischemic and 5.0 hemorrhagic strokes per 1000 patient-years, a ratio of approximately 4.5:1. Chronic AF was independently associated with time to ischemic (hazard ratio [HR], 1.26; 99% confidence interval [CI], 1.06-1.49; P = .0005), but not hemorrhagic, stroke. Race was strongly associated with hemorrhagic stroke: African Americans (HR, 1.46; 99% CI, 1.08-1.96), Hispanics (HR, 1.64; 99% CI, 1.16-2.31), and others (HR, 1.76; 99% CI, 1.16-2.78) had higher rates than did Caucasians (all P < .001).
CONCLUSIONS: Chronic AF has a significant, but modest, association with ischemic stroke. Race/ethnicity is strongly associated with hemorrhagic strokes. The proportion of strokes owing to hemorrhage is much higher than in the general population.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23332588      PMCID: PMC3570646          DOI: 10.1016/j.annepidem.2012.12.011

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  26 in total

1.  Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Authors:  A S Go; E M Hylek; L H Borowsky; K A Phillips; J V Selby; D E Singer
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

2.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

3.  Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group.

Authors:  K Iseki; K Fukiyama
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

4.  Predictors of stroke in patients receiving chronic hemodialysis.

Authors:  K Iseki; K Fukiyama
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

5.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

6.  Elevated risk of stroke among patients with end-stage renal disease.

Authors:  Stephen L Seliger; Daniel L Gillen; W T Longstreth; Bryan Kestenbaum; Catherine O Stehman-Breen
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

Review 7.  Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Gladys Block; Tamara Horwich; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

8.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

9.  Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis.

Authors:  M Kawamura; S Fijimoto; S Hisanaga; Y Yamamoto; T Eto
Journal:  Am J Kidney Dis       Date:  1998-06       Impact factor: 8.860

10.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Authors:  Alan S Go; Elaine M Hylek; Yuchiao Chang; Kathleen A Phillips; Lori E Henault; Angela M Capra; Nancy G Jensvold; Joe V Selby; Daniel E Singer
Journal:  JAMA       Date:  2003-11-26       Impact factor: 56.272

View more
  31 in total

1.  Stroke and the "stroke belt" in dialysis: contribution of patient characteristics to ischemic stroke rate and its geographic variation.

Authors:  James B Wetmore; Edward F Ellerbeck; Jonathan D Mahnken; Milind A Phadnis; Sally K Rigler; John A Spertus; Xinhua Zhou; Purna Mukhopadhyay; Theresa I Shireman
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

Review 2.  Cardiovascular complications in chronic dialysis patients.

Authors:  Thomas A Mavrakanas; David M Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

3.  Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients.

Authors:  James B Wetmore; Milind A Phadnis; Jonathan D Mahnken; Edward F Ellerbeck; Sally K Rigler; Xinhua Zhou; Theresa I Shireman
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

4.  Atrial fibrillation and kidney disease: insights on a close relationship.

Authors:  Giorgio Trivioli
Journal:  Intern Emerg Med       Date:  2019-07-17       Impact factor: 3.397

5.  Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1.

Authors:  Nisha Bansal
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

6.  Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis.

Authors:  Medha Airy; Tara I Chang; Victoria Y Ding; Benjamin A Goldstein; Nisha Bansal; Jingbo Niu; Sankar D Navaneethan; Mintu P Turakhia; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

7.  Estimation of Drug Effectiveness by Modeling Three Time-dependent Covariates: An Application to Data on Cardioprotective Medications in the Chronic Dialysis Population.

Authors:  Milind A Phadnis; Theresa I Shireman; James B Wetmore; Sally K Rigler; Xinhua Zhou; John A Spertus; Edward F Ellerbeck; Jonathan D Mahnken
Journal:  Stat Biopharm Res       Date:  2014       Impact factor: 1.452

8.  Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.

Authors:  Jose A Gómez-Puerta; Candace H Feldman; Graciela S Alarcón; Hongshu Guan; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

Review 9.  Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.

Authors:  Austin Hu; Jingbo Niu; Wolfgang C Winkelmayer
Journal:  Semin Nephrol       Date:  2018-11       Impact factor: 5.299

Review 10.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.